Drug and medical device industries continue to target clinicians early in their careers, including during training, through payments, free meals, and sponsored education.
What solutions are needed at individual and institutional levels? @QuinnGrundy
https://t.co/AD9w0iGTkx
Multi-stakeholder approaches are increasingly being used to deal with the challenges posed by unsustainable global #foodsystems. 🍔 🥤
🆕research provides evidence that these #multistakeholder initiatives enable corporations to dominate decision making.
https://t.co/Nv14CLxuUY
📢 Landmark new report: Commercial Determinants of NCDs 📢
Chronic diseases account for 90% of deaths in the Region. New research highlights how big industries fuel them, obstructing health policy and targeting the vulnerable.
https://t.co/8bns6JeN9e
#NCDs#CDoH#SDGs#R2F
"We suggest that industry corporate political activity is recognised as a corruption of democracy, not an element of participatory democracy". New paper in @IJHPM looks at corporate influence on policy w/ @BathTR @MIALONMelissa @kathrin_lauber @ali_fabbri
https://t.co/vvDVrUa6x2
‘Policy inertia’ is enabling the products and practices of some commercial actors to cause significant, ongoing harm to health, warn experts.
A new Lancet Series argues for a bold system overhaul that puts people and planet first: https://t.co/M3XfokxNok
Our new animation launches today! Find out more about SPECTRUM and our research into the commercial determinants of health 🔎💷
Watch the trailer here or view in full on our website https://t.co/TVZcm5yblU
#CDoH
New paper! @Britta_KM and others from @BathTR examine #tobaccoindustry involvement in scientific events, and emphasise the need to be aware of the industry's "renewed assault on science". @TC_BMJ
https://t.co/sSRTx4MmnL
Pleased to share a new podcast called Money Power Health! I look forward to discussing health inequalities and #CDoH with as many interesting people as I can! You can find the 1st episode here with special guest @sandrogalea: https://t.co/qlJkoLFXNF DMs always open for ideas!
🚨 Our new book "The Commercial Determinants of Health" is now available for pre-order from @OUPAcademic! V grateful to co-editors @petticrewmark@sandrogalea for their partnership on this project. #CDOH https://t.co/kurOpu0AwA
Want to know more about the commercial determinants of health? Then listen to @SharonFrielOz Jonathan Liberman and me in conversation with Carmel Williams @evelynedeleeuw@HealthPromInt View us here https://t.co/KQwQIChCNK
⚡️ New paper just out from our research group! "Manufacturing doubt: Assessing the effects of independent vs industry-sponsored messaging about the harms of fossil fuels, smoking, alcohol, and sugar sweetened beverages" #CDOH@SPECTRUMRes https://t.co/542fPwh4aF 🧵below!
What is conflict of interest?
How would corporate practices be harmful to health and what is their influence on research?
AND don’t miss plenty of resources on #COI in this recorded webinar
https://t.co/O3GwGHQu3A
MarcRodwin @NPaichadze@ali_fabbri
As we close the week, a little bit of weekend reading!
Delighted to share the hot-off-the-press 👇👇
WHO Factsheet on the Commercial Determinants of Health: https://t.co/2rpvGXdRCb
New systematic review just out: "There is substantial evidence of frequent relationships between cancer physicians and the pharmaceutical industry..."
https://t.co/q7FTazvZW7
New research published in @PLOSONE from @tess_legg + @BathTR@UniofBath co-authors shows how major industries use science to delay progress in tackling threats to human and planetary health by obscuring industry harms and opposing regulation.
https://t.co/pbnVl3TvOf